Bio Summary:
Prof. Yansong Guo is a distinguished male cardiologist, currently serving as a Professor of Cardiology and Consultant Cardiologist at Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China. With a career spanning 30 years, Prof. Guo specializes in Interventional Cardiology, particularly focusing on coronary intervention, structural heart disease intervention, and heart failure.
Education:
- Qualification: MD FACC
- Medical School: Fujian Medical University
- Post-Doctoral Studies: University of Rochester, USA (Aug. 2009 – Aug. 2010)
Research Focus:
Prof. Guo’s research primarily revolves around cardiovascular medicine, with specific interests in interventional cardiology, heart failure, and clinical and basic research in cardiology. His innovative work includes exploring the role of post-dilatation in Primary Percutaneous Coronary Intervention (PPCI) using quantitative flow ratio (ΞΌQFR) and angiographic microcirculatory resistance.
Professional Journey:
- Junior Doctor: Fujian Provincial Hospital
- Professor of Cardiology: Fujian Medical University
- Director: Fujian Provincial Key Laboratory of Cardiovascular Disease
- Director: Fujian Heart Failure Center Alliance
Honors & Awards:
- Recipient of Provincial Medical Science and Technology Awards
- Multiple Fujian Provincial Science and Technology Progress Awards
- Recognized for leadership and contributions in the field
Research Timeline:
- Total Experience: 30 years
- Post-Doctoral Studies: University of Rochester, USA (Aug. 2009 – Aug. 2010)
- Current Position: Professor of Cardiology, Fujian Medical University
Prof. Yansong Guo’s impactful contributions to the field of cardiology, extensive research, and leadership roles showcase his dedication to advancing cardiovascular medicine. His work challenges existing practices and opens avenues for further investigation in the diagnosis and treatment of cardiovascular diseases.
Author Metrics:
- Citations: 261
- Documents: 54
- H-index: 10 (based on Scopus/Web of Science)
- Citation Index: 260 (Scopus/Web of Science/PubMed)
- Cumulative Impact Factor (last 3 years): 114
View all metrics and document details (disabled in preview mode)
Document & Citation Trends:
- Publications span from 2011 to 2024
- Citations received across various documents each year
- Diverse topics covered in research
Interactive chart displaying document and citation trends (disabled in preview mode)
Publications Top Noted & Contributions:
- Author of over 50 manuscripts in peer-reviewed literature
- Led a multi-center clinical study (REDUCTION)
- Published in SCI, SCIE, Scopus, Web of Science, and PubMed indexed journals
Title: Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk
- Published in Cardiovascular Diabetology, 2023
- 1 Citation
Title: Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCCβACS (improving care for cardiovascular disease in China-acute coronary syndrome) project
- Published in European Journal of Medical Research, 2023
- 0 Citations
Title: The optimal definition and prediction nomogram for left ventricular remodelling after acute myocardial infarction
- Published in ESC Heart Failure, 2023
- 0 Citations
Title: Association of ambient PM10 and PM2.5 with coronary stenosis measured using selective coronary angiography
- Published in Ecotoxicology and Environmental Safety, 2023
- 0 Citations
Title: Shrunken Pore Syndrome: A New and More Powerful Phenotype of Renal Dysfunction Than Chronic Kidney Disease for Predicting Contrast-Associated Acute Kidney Injury
- Published in Journal of the American Heart Association, 2023
- 2 Citations
